| Main Title |
Commercial Simian Virus Antisera that Inhibit Virus Replication in Primary Monkey Kidney Cell Cultures. |
| Author |
Hughes, John H. ;
Hamparian, Vincent V. ;
|
| CORP Author |
Ohio State Univ., Columbus. Coll. of Medicine.;Health Effects Research Lab., Cincinnati, OH. |
| Year Published |
1981 |
| Report Number |
EPA-S-805189; EPA-600/J-81-292; |
| Stock Number |
PB81-232084 |
| Additional Subjects |
Cell cultures ;
Immune serums ;
Viruses ;
Monkeys ;
Culture media ;
Kidney ;
Reprints ;
|
| Holdings |
| Library |
Call Number |
Additional Info |
Location |
Last
Modified |
Checkout
Status |
| NTIS |
PB81-232084 |
Some EPA libraries have a fiche copy filed under the call number shown. |
|
07/26/2022 |
|
| Collation |
6p |
| Abstract |
The incorporation of hyperimmune serum into cell culture medium to control endogenous viral infections of primary cells can have a significant effect on the replication of other viruses. When commercial simian virus 5 or simian virus 40 antiserum was used with primary monkey kidney cell cultures, the authors found a significant inhibition (>90%) of the replication of parainfluenza virus types 2 and 3 and reovirus type 1. In the viral diagnostic laboratory, the use of hyperimmune serum with primary monkey kidney cells may result in failure to isolate certain viruses if these cells are not first washed free of hyperimmune serum. |
